Syringes and needles in Saudi Arabia are the sterile single-use hypodermic syringes, needles, insulin syringes and safety devices used across government and private hospitals and primary care. This page lists Saudi suppliers and covers what governs the purchase: ISO 7886 standards adopted by SFDA technical committee TC 84, device classification under MDS-REQ 1, safety and re-use prevention designs, and tender and supply points.
0 suppliers found
Skip the search. Post your requirement and we'll connect you with verified syringes & needles suppliers who quote for your order directly.
Tell us about syringes & needles in Saudi Arabia and receive competitive quotes from verified suppliers — free, fast, and no obligation.
Saudi hospitals, primary care centres and vaccination services buy hypodermic syringes, needles, insulin syringes and safety-engineered injection devices in very high volumes, mostly on annual contracts. These products are part of the medical consumables family for Saudi Arabia, where SFDA import, shelf life and data logger rules are explained; below are the product decisions.
| Device | Main Saudi use | Standard |
|---|---|---|
| Hypodermic syringe for manual use | Wards, emergency, clinics | ISO 7886-1:2017 (adopted by SFDA with modifications) |
| Syringe with re-use prevention feature | General injections where reuse must be impossible | ISO 7886-4 (adopted by SFDA with modifications) |
| Auto-disable syringe | Fixed-dose immunization | ISO 7886-3 |
| Insulin syringe | Diabetes care in hospitals and primary care | ISO 8537:2016 (adopted by SFDA with modifications) |
| Pen needle | Insulin and other pen injectors | ISO 11608-2:2012 (adopted by SFDA) |
| Hypodermic needle | Injection and drawing up | ISO 7864 |
| Safety needle or syringe | Needlestick prevention | ISO 23908:2024 |
Cannulas, IV administration sets and catheters are a separate line under IV sets and catheters in Saudi Arabia, and alcohol swabs, cotton and kits come from general disposable medical supplies.
SFDA technical committee SFDA/MDS/TC 84, "Devices for administration of medicinal products and catheters", has adopted several ISO syringe and needle standards as Saudi national standards, some with modifications. SFDA publishes the adoption documents, including ISO 7886-1:2017, ISO 7886-4:2018, ISO 8537:2016 and ISO 11608-2.
The ISO 7886-4:2018 adoption shows what "with modifications" means in practice. SFDA reworded the feature definition so that the re-use prevention mechanism may activate before or at the end of the injection, renamed the first type as an auto reuse prevention feature to avoid confusion with immunization auto-disable syringes, and added a requirement that the labelling include the manufacturer's contact information as well as its identity. Two other adoptions change labels. The Saudi ISO 7886-1:2017 adds the production date to the syringe labelling, which SFDA links to calculating the share of total shelf life, and the Saudi ISO 8537:2016 for insulin syringes replaces the old ISO 594-1 luer reference with ISO 80369-7:2016 and requires the manufacturer's name and, where applicable, the authorised representative on the marking. Ask suppliers whether their labels and test reports follow the Saudi versions, not only the ISO text.
SFDA defines standards as non-mandatory documents, but MDS-REQ 1 requires proof of conformity with the Essential Principles, and recognised standards are the usual way to provide it. As of 2026, confirm the current adoption list on the SFDA site before a tender.
Classification decides how much evidence SFDA reviews. Under the classification rules in MDS-REQ 1 version 6, all surgically invasive devices for transient use are class B under Rule 6, with exceptions such as devices that administer medicinal products in a potentially hazardous way, which become class C. A hypodermic needle used for an injection is a surgically invasive, transient device, so the manufacturer applies Rule 6 and states the result in the file; check the class on each product's Medical Device Marketing Authorization rather than assuming it.
Needlestick injuries expose staff to bloodborne viruses, so hospitals increasingly ask for safety-engineered devices. The WHO guideline on safety-engineered syringes for intramuscular, intradermal and subcutaneous injections (2016) makes recommendations on both re-use prevention and sharps injury protection syringes.
Syringes travel well, but the rubber plunger stopper and blister seals still need storage within label limits, and long summer hauls from central warehouses to regional hospitals are the risk point. Air conditioned warehousing and covered transport protect the sterile packs, and receiving staff should reject crushed or wet cartons.
Plan stock by item, not by family. Insulin syringes and pen needles move steadily through primary care and pharmacies, while pump syringes and large volumes follow ICU and theatre activity. Because syringes labelled to the Saudi version of ISO 7886-1 carry a production date as well as an expiry date, warehouse teams can check remaining shelf life against hospital contract terms on receipt, and send short-dated lots back before they reach the ward.
Supply comes from Saudi manufacturers and from authorised representatives and distributors of overseas makers, all needing SFDA marketing authorisation for every item and an SFDA-licensed warehouse. Government volume runs through NUPCO tenders; private groups buy on annual agreements.
The same distributors often quote surgical and examination gloves and wound care products. To collect quotes, post your requirement with volumes, sizes, needle combinations and safety features.